Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S205-7.

DANBIO: a nationwide registry of biological therapies in Denmark.

Author information

1
DANBIO, Copenhagen University Hospital at Hvidovre, Department of Rheumatology, Hvidovre, Denmark. merete.hetland@dadlnet.dk

Abstract

Since the year 2000, Danish rheumatologists have been collecting data on a routine basis in the nationwide DANBIO registry, which includes all rheumatologic patients receiving biological drugs. Demographic data, markers of disease activity, current treatment, serious and non-serious adverse events and reasons for discontinuation are registered at each visit either on paper forms or on-line. By June 2005, approximately 3000 treatment courses (18,000 visits) were in the registry, corresponding to close to 90% of eligible patients. Rheumatoid arthritis was the most prevalent diagnosis (75%) followed by ankylosing spondylitis (11%) and psoriatic arthritis (7%). Infections occurred in 43% of the treatment series.

PMID:
16273809
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center